Igor Matushansky, MD, PhD

Overview
For over 20 years Dr. Matushansky’s clinical practice has focused exclusively on the treatment and care of patients with sarcomas (i.e., cancers of musculoskeletal origins) and/or sarcoma related diseases.
Dr. Matushansky earned a BA degree from Columbia College, Columbia University and MD & PhD degrees from Albert Einstein College of Medicine. He performed his internal medicine residency at New York Presbyterian Hospital/Weill Cornell Medical Center and then completed a fellowship in Medical Oncology, as well as a post-doctoral research fellowship in Cancer Biology at Memorial Sloan Kettering Cancer Center.
In addition to his clinical focus Dr. Matushansky is currently Chief Medical Officer at Sail BioMedicines, a preclinical company focusing on developing programmable medicines.
Areas of Expertise / Conditions Treated
- Ewing's Sarcoma
- Mesothelioma
- Sarcoma
- Soft Tissue Sarcoma
- Solid Tumors
Academic Appointments
- Assistant Professor of Medicine at CUMC
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Male
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- Aetna Signature Administrators
- NYP Employee Plan
- NY Signature
- Student Health
Amida Care
- Special Needs
Cigna
- Great West (National)
Emblem/GHI
- Medicare Managed Care
Emblem/HIP
- Essential Plan
- Select Care (Exchange)
- Vytra
Empire Blue Cross/Blue Shield
- EPO
- HMO
- Medicare Managed Care
- PPO
Local 1199
- Local 1199
Medicare
- Railroad
- Traditional Medicare
Multiplan
- Multiplan
UnitedHealthcare
- Compass (Exchange)
- Empire Plan
- Oxford Freedom
- Oxford HMO
- Oxford Liberty
- POS
VNSNY CHOICE
- SelectHealth
World Trade Center Health Plan
- World Trade Center Health Plan
Credentials & Experience
Education & Training
- Albert Einstein College of Medicine of Yeshiva University
- Internship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
- Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
- Fellowship: Memorial Sloan-Kettering Cancer Center, NY
Board Certifications
- Internal Medicine
- Medical Oncology
Research
Selected Publications
Chemotherapy use in elderly patients with soft tissue sarcoma: a population-based study.
Matushansky I, Dela Cruz F, Insel BJ, Hershman DL, Neugut AI.
Cancer Invest. 2013 Feb;31(2):83-91. doi: 10.3109/07357907.2012.756112. Epub 2013 Jan 15.
PMID: 23320812
PPARγ agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma.
Charytonowicz E, Terry M, Coakley K, Telis L, Remotti F, Cordon-Cardo C, Taub RN, Matushansky I.
J Clin Invest. 2012 Mar;122(3):886-98. doi: 10.1172/JCI60015. Epub 2012 Feb 1.
PMID: 22293175
Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma.
Matushansky I, Taub RN.
Nat Rev Clin Oncol. 2011 Mar 22;8(7):434-8. doi: 10.1038/nrclinonc.2011.36.
PMID: 21423256
MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century.
Matushansky I, Charytonowicz E, Mills J, Siddiqi S, Hricik T, Cordon-Cardo C.
Expert Rev Anticancer Ther. 2009 Aug;9(8):1135-44. doi: 10.1586/era.09.76.
PMID: 19671033
Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway.
Matushansky I, Hernando E, Socci ND, Mills JE, Matos TA, Edgar MA, Singer S, Maki RG, Cordon-Cardo C.
J Clin Invest. 2007 Nov;117(11):3248-57. doi: 10.1172/JCI31377.
PMID: 17948129
Mechanisms of sarcomagenesis.
Matushansky I, Maki RG.
Hematol Oncol Clin North Am. 2005 Jun;19(3):427-49, v. doi: 10.1016/j.hoc.2005.03.006.
PMID: 15939190